DBVT DBV Technologies S.A.: Accounting Value per Share

DBV Technologies S.A. (DBVT) is developing a unique non-injectable method for combating peanut allergies via the Viaskin system, which is particularly valuable for children. This daily price chart, with a value of 2.70, confirms the brand's status as a trusted innovator in dermatology. The company is currently focusing on completing clinical trials and seeking major partners, while completely ignoring a mergers and acquisitions strategy.

DBV Technologies SA (DBVT): Share Book Value from 07/04/2022 to 10/27/2026

DBV Tech - analytical breakdowns and key metrics (DBVT)

- price and consensus price forecast:

Stock Quotes DBV Technologies SA|DBVT - Price Target Chart

- market capitalization data:

Market Valuation DBV Technologies S.A.|DBVT - Aggregate Business Value

- book capitalization data:

Net Assets per Single Share DBV Technologies|DBVT - Net Asset Value|Market Capitalization to Book Value Ratio dbv-technologies.com|DBVT - Aggregate Asset Value

- debt and liquidity data:

Total Debt to Capital DBV Technologies S.A.|DBVT - Long-Term Debt to Capital|Short-Term Debt to Equity DBV Technologies SA|DBVT - Aggregate Debt Obligations|Debt to Book Capitalization Ratio DBV Technologies S.A.

Fundamental company valuation:dbv-technologies.com - DBVT

Manufactured products of DBV Technologies SA

A low price-to-book multiple indicates a potential discount, allowing investors to assess the intrinsic value of assets relative to market quotes. Analyzing the absolute level of the book value per share, we see the portion of net equity per security, which for DBV Technologies S.A. (DBVT) will serve as the foundation for growth upon the market launch of a unique allergy patch with high pricing power.

Competitors of DBV Technologies S.A. (DBVT)

KRYS - Accounting Value per Share|Apogee Corp (APGE) - Net Assets per Single Share|ARQT - Accounting Value per Share|VCEL (vcel.com) - Book Price of a Share|Net Assets per Single Share Oruka Therapeutics ORKA|Share Book Value Sanara|Solesence Inc (SLSN) - Book Value per Share|Accounting Value of a Share journeymedicalcorp.com (DERM)|Book Value per Share FBRX (Forte Biosciences, Inc.)|empro.my - Book Value per Share|Net Assets per Single Share Sol-Gel Technologies Ltd. (SLGL)|AXIL: Accounting Value of a Share|MDCX (Medicus Pharma Limited) - Net Assets per Single Share|Verrica Pharmaceuticals Inc. (VRCA) - Accounting Value per Share|HOTH (Hoth Therapeutics Inc.) - Book Value per Share|Book Value per Share Biofrontera Inc (BFRI)|VYNE Therapeutics (VYNE) - Accounting Value per Share|Accounting Value of a Share SNOA (sonomapharma.com)|Net Assets per Single Share QNRX|Azitra Corporation - Net Assets per Share|Dermata Therapeutics - Net Assets per Single Share|ELAB - Book Value per Share|Revance Therapeutics, Inc. - Book Value per Share